← All trials
NCT03058289
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 9, 2017
- Primary completion
- Jul 1, 2018
- Completion date
- Jan 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 60
- Arms / groups
- 9 / —
- Source
- AACT · pre-existing
Sponsors
- Intensity TherapeuticsLead sponsor
- University of Southern CaliforniaOverall official - principal investigator
- Intensity TherapeuticsStudy director
- University of Southern CaliforniaCollaborator
- University of TorontoCollaborator
- University of TorontoStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.